- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Olaparib – July 2016
Olaparib: 50 mg capsule, 4 x 112 capsules, Lynparza™
Last updated
11 November 2016